Peripartum cardiomyopathy
From Wikipedia, the free encyclopedia
Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy that is defined as a deterioration in cardiac function presenting between the last month of gestation and up to five months post-partum.
As with other forms of dilated cardiomyopathy, PPCM involves decrease of the left ventricular ejection fraction with associated congestive heart failure and increased risk of atrial and ventricular arrhythmias and even sudden cardiac death.
The etiology of postpartum cardiomyopathy is unknown.
Contents |
[edit] Risk factors
In the US he prevalence is estimated to be 1 case per 1300-15,000 live births.
The incidence of peripartum cardiomyopathy is increased in women over the age of 30, in twin pregnancies, in multiparous women, in women with gestational hypertension, those who have received tocolytic therapy, and in african americans.
[edit] Clinical Features (History)
Pregnancy itself brings about some features that suggest cardiac insufficiency. Symptoms such as dyspnoea, dizziness, orthopnoea and decreased exercise tolerance are often normal findings in pregnancy.
Moreover, the normal cardiac physiology changes dramatically in the gravid female. Blood volume increases progressively from 6-8 weeks gestation (pregnancy) and reaches a maximum at approximately 32-34 weeks with little change thereafter. During the first trimester cardiac output is 30-40% higher than in the non-pregnant state; there is also an approximately 35% increase in stroke volume, a 15% increase in HR and a steady decrease in vascular resistance.
The dyspnoea is described usually by the woman as the inability to take a deep breath in to get enough air into her lungs. It is thought that the hormonal (progesterone) mediated hyperventilation seen in pregnancy is the cause.
In PPCM the symptoms secondary to acute onset of heart failure seen are similar to patients with systolic dysfunction who are not pregnant. These symptoms include cough, orthopnoea, paroxysmal nocturnal dyspnoea, fatigue, palpitations, haemoptysis and chest pain. These symptoms mimic many normal pregnant women who cannot tolerate lying flat, have significant pedal edema, complain of shortness of breath and dyspnea but have no heart disease.
The challenge facing physicians is to differentiate between these two groups and diagnose women with PPCM sooner than later as early intervention has shown benefit and may save lives.
[edit] Prognosis
Mortality rates range anywhere between 9% and 56%. About 50 to 60 percent of women with postpartum cardiomyopathy have improvement or total recovery in their left ventricular function within 6 months of diagnosis. The remainder tend to have either stabilization of their ventricular function or worsening (requiring cardiac transplantation).1 Women are strongly discouraged form subsequent pregnancies as numerous studies have demonstrated reccurrence of the disease. The [Pregnancy-Related Cardiomyopathy Enrollment and Lessons in Web-based Recruitment (PRiCELESS)] study is an ongoing registry seeking to answer many of the questions left unanswered because of the rarity of the disease. For more infromation about the study, one can visit [1].
Treatment for this disease varies widely reflecting the range of severity. While some patients with severe left ventricular dysfunction (less than 35%) may proceed to cardiac tranplant or require an automated internal cardiac defibrillator (AICD) and standard heart failure therapy, others may return to normal cardiac function and reuqire little, if any, additional medical therapy. However, all women should be strongly discouraged from having subsequent pregnancies.
[edit] References
1. Ravikishore AG, Kaul UA, Sethi KK, Khalilullah M. Peripartum cardiomyopathy: prognostic variables at initial evaluation. Int J Cardiol. 1991 Sep;32(3):377-80. (Medline abstract) 2. Ro, Angela; Frishman, William. Cardiology in Review 2006;14: 35–42
 |
This medical article is a stub. You can help Wikipedia by expanding it. |
